on Monday reported preliminary second-quarter sales below analysts' estimates due to weak performance at its healthcare segment, sending the medical device maker's shares down about 28% in after-market trading.
The company forecast consolidated revenue for the second quarter between $453 million and $457 million, compared with estimates of $553.2 million, according to Refinitiv. Masimo said an increase in costs related to hospital personnel hit equipment demand during the quarter. It also reported lower demand for single-patient use sensors.
"On the consumer side, it is unclear when the softness in the premium and luxury categories will improve," the company said.Reporting by Savyata Mishra in Bengaluru; Editing by Shounak Dasgupta
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: